Whitepaper : Viatris | Rapidly Diffusing New Knowledge On Novel Medicines For COVID-19 In India | Medical Learning Hub


Posted October 19, 2022 by medicallearninghub

✅ Download the Whitepaper: https://bit.ly/3Rt0k8p Read the whitepaper on how Mylan, a Viatris reach the healthcare professionals across India to increase the clinician knowledge for managing the COVID 19 patients and COVID Care.
 
At a glance
A leading maker of medicines for global markets used MLH to host 69 knowledge ¬sharing webinars on COVID-19 during 2020 and 2021, attracting 65,448 registrations from healthcare providers.

Challenges
Mylan, a Viatris company, is a global top 5 generics pharmaceutical that was licensed to supply two anti-viral medicines for use with COVID-19 patients. Due to India's rising COVID-19 instances, clinicians needed to learn how to use these novel medicines. But how to quickly contact India's millions of healthcare providers (HCPs)?

Solutions
TC4A approached Mylan with a plan to spread scientific evidence-based awareness & engage HCPs across the country. The objective was to engage 50,000 HCPs through Medical Learning Hub, & TC4A India worked to secure expert speakers, panelists & partner healthcare organizations on COVI D-19 topics.
Tapping our extensive user base & partnerships with scientific associations, we reached out to about >3 Lac HCPs across India to promote the courses.
We hosted 69 knowledge-sharing webinars extending through 2020 - 2021 - at a pace of more than two per month .
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Medical Learning Hub
Country India
Categories Education , Health , Medical
Tags viatris whitepaper , medical learning hub , continuing medical education , healthcare professionals , viatris covid 19 webinars , medical education cme , cme platform , hcps engagement
Last Updated October 19, 2022